Literature DB >> 16169342

Cilostazol improves long-term outcomes after coronary stent implantation.

Yaling Han1, Shouli Wang, Yi Li, Quanmin Jing, Yingyan Ma, Jie Deng, Guitang Yang, Haibo Yu, Junbo Ge.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16169342     DOI： 10.1016/j.ahj.2005.06.021

Source DB:  PubMed          Journal:  Am Heart J        ISSN： 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  3 in total

1.  Cilostazol prevents progression of asymptomatic carotid artery stenosis in patients with contralateral carotid artery stenting.

Authors:  T Kato; H Sakai; T Takagi; Y Nishimura
Journal:  AJNR Am J Neuroradiol       Date:  2012-02-09       Impact factor: 3.825

Review 2.  Management Strategies for Clopidogrel Hypersensitivity.

Authors:  Craig J Beavers; Nicolas W Carris; Kathryn M Ruf
Journal:  Drugs       Date:  2015-06       Impact factor: 9.546

3.  Comparison of cilostazol versus ticlopidine following coronary stenting in patients with coronary heart disease: A meta-analysis of randomized controlled trials.

Authors:  Feng-Huan Hu; Xin Yi; Yue-Jing Yang; Shu-Bin Qiao; Yong-Jian Wu; Jian-Song Yuan
Journal:  Exp Ther Med       Date:  2013-07-01       Impact factor: 2.447
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.